Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$56 Mln
P/E Ratio
--
P/B Ratio
0.33
Industry P/E
--
Debt to Equity
2.31
ROE
-0.57 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
-4.6
CFO
$45.98 Mln
EBITDA
$8.92 Mln
Net Profit
$-439.50 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Inotiv (NOTV)
| -61.11 | -42.81 | -62.30 | -62.73 | -59.76 | -17.65 | -2.58 |
|
BSE Sensex*
| 1.74 | 3.52 | 4.98 | 8.93 | 11.19 | 21.05 | 11.14 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Inotiv (NOTV)
| 12.70 | -25.71 | -88.26 | 242.03 | 148.48 | 289.76 | -47.98 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 35.59 | 9,973.38 | 20.56 | 23.13 | |
| 288.99 | 8,956.07 | 23.48 | 58.42 | |
| 25.13 | 9,559.25 | -- | -28.77 | |
| 100.68 | 10,030.35 | 30.81 | 14.16 |
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. It operates through two segments, Discovery and... Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana. Address: 2701 Kent Avenue, West Lafayette, IN, United States, 47906 Read more
President, CEO & Director
Mr. Robert W. Leasure Jr.
President, CEO & Director
Mr. Robert W. Leasure Jr.
Headquarters
West Lafayette, IN
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Inotiv Inc (NOTV) stood at $ 882 Mln as on 31-Dec-24
The share price of Inotiv Inc (NOTV) is $1.61 (NASDAQ) as of 21-Apr-2025 16:00 EDT. Inotiv Inc (NOTV) has given a return of -59.76% in the last 3 years.
Inotiv Inc (NOTV) has a market capitalisation of $ 56 Mln as on 21-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Inotiv Inc (NOTV) is 0.33 times as on 21-Apr-2025, a 85% discount to its peers’ median range of 2.25 times.
Since, TTM earnings of Inotiv Inc (NOTV) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Inotiv Inc (NOTV) and enter the required number of quantities and click on buy to purchase the shares of Inotiv Inc (NOTV).
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana. Address: 2701 Kent Avenue, West Lafayette, IN, United States, 47906
The CEO & director of Mr. Robert W. Leasure Jr.. is Inotiv Inc (NOTV), and CFO & Sr. VP is Mr. Robert W. Leasure Jr..
There is no promoter pledging in Inotiv Inc (NOTV).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,012
|
|
|
990
|
|
|
974
|
|
|
896
|
| Inotiv Inc. (NOTV) | Ratios |
|---|---|
|
Return on equity(%)
|
-68.58
|
|
Operating margin(%)
|
-19.34
|
|
Net Margin(%)
|
-25.4
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Inotiv Inc (NOTV) was $0 Mln.
$-0.03
(
